Jianghua Tu
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 8
- Pharmacological Effects of Natural Compounds 2
- Transplantation top 5%
-
- Drug Transport and Resistance Mechanisms 7
- Cancer Treatment and Pharmacology 2
- Cancer Cells and Metastasis 2
-
- Pharmacological Effects and Toxicity Studies 3
-
- Peroxisome Proliferator-Activated Receptors 2
- Wnt/β-catenin signaling in development and cancer 2
- Cited by
- PharmacologyTransplantationOncology
- Journals
- Scientific Reports (2 papers)Journal of Medicinal Chemistry (1 paper)Clinica Chimica Acta (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jianghua Tu
17 papers receiving 572 citations
Peers
Comparison fields: 5 of 75
- Pharmacology 243
- Transplantation 60
- Oncology 197
- Pediatrics, Perinatology and Child Health 129
- Complementary and alternative medicine 44
Countries citing papers authored by Jianghua Tu
This map shows the geographic impact of Jianghua Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghua Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghua Tu more than expected).
Fields of papers citing papers by Jianghua Tu
This network shows the impact of papers produced by Jianghua Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghua Tu. The network helps show where Jianghua Tu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianghua Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 9 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 28 | |
| 5 | 2019 | 46 | |
| 6 | 2015 | 36 | |
| 7 | 2010 | 31 | |
| 8 | 2010 | 56 | |
| 9 | 2009 | 33 | |
| 10 | 2009 | 70 | |
| 11 | 2009 | 56 | |
| 12 | 2009 | 28 | |
| 13 | 2009 | 25 | |
| 14 | 2008 | 24 | |
| 15 | 2007 | 52 | |
| 16 | 2006 | 72 | |
| 17 | [Protective effect of Na(+)-H+ exchanger inhibitor cariporide on the injury of vascular endothelial function induced by hypercholesterolemia]. | 2002 | 3 |
About Jianghua Tu
Jianghua Tu is a scholar working on Pharmacology, Oncology and Transplantation, having authored 17 papers that have together received 582 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Cells and Metastasis (2 papers), Pharmacological Effects of Natural Compounds (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Pharmacology (243 citations), Transplantation (60 citations) and Oncology (197 citations). Jianghua Tu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhi‐Rong Tan, Gan Zhou, Yao Chen, Lan Fan, Hong‐Hao Zhou, Yijing He, Zhaoqian Liu, Dongli Hu, Ling Wu and Kendra S. Carmon. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.